Research Reports

Key takeaways

Board approved 1-for-20 reverse stock split (Split Ratio) following shareholder approval on March 31, 2026.

Effective Date is 12:01 a.m. ET on April 28, 2026, with split-adjusted trading at market open.

Every 20 pre-split shares convert to 1 post-split share; no fractional shares issued, with whole shares or cash in lieu.

Proportionate adjustments apply to equity incentive awards, warrants, convertible notes, and other equity instruments.

Consideration includes terms of prior financings with Lind Global Asset Management XII LLC on May 20, 2025 and January 15, 2026.

Full analysis

The reverse stock split at a 1-for-20 ratio consolidates outstanding common stock shares, reducing the total number by converting every 20 shares into one, effective April 28, 2026. This action fulfills the shareholder-approved proposal from the March 31, 2026 special meeting, granting the Board discretion on the ratio. No fractional shares will result, ensuring all holders receive whole shares or cash equivalents where applicable. Adjustments extend to the 2015 and 2024 Stock Incentive Plans, warrants, convertible notes, and other equity instruments, maintaining their proportionate value. The decision aligns with financing agreements with Lind Global Asset Management XII LLC, potentially supporting compliance or strategic capital structure goals for investors.

VNRX · VolitionRx Limited

Summary

Key takeaways

Full analysis